Horm Metab Res 2010; 42(13): 987-990
DOI: 10.1055/s-0030-1265224
Short Communication

© Georg Thieme Verlag KG Stuttgart · New York

Pioglitazone has Direct Effects on Insulin Sensitivity and Intracellular Lipid Content in L6 Skeletal Muscle Cells

M. Kranebitter[*] , A. Niederwanger[*] , T. Tatarczyk1 , C. Ciardi1 , R. Al-Zoairy1 , J. R. Patsch1 , M. T. Pedrini1
  • 1Department of Internal Medicine I, Innsbruck Medical University, Innsbruck, Austria
Weitere Informationen

Publikationsverlauf

received 23.06.2010

accepted 02.09.2010

Publikationsdatum:
13. Oktober 2010 (online)

Abstract

Using L6 skeletal muscle cell line, rendered insulin resistant by incubation with triglyceride-rich lipoproteins (TGRLs), we sought to answer the question whether pioglitazone has direct effects on this cell line. Incubation of L6 cells with TGRLs led to an increase in the intramyocellular triglyceride content. Moreover, TGRLs led to a reduction in insulin-stimulated glycogen content and GSK-3 phoshorylation. All these changes induced by TGRLs could be antagonized by incubation of L6 cells with pioglitazone. The PPAR-γ antagonist GW9662 reversed the pioglitazone effects. We conclude that pioglitazone has direct insulin-sensitizing effects on the L6 skeletal muscle cell line, which are paralleled by a reduction in intramyocellular triglyceride accumulation.

References

  • 1 Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. Nature. 2001;  409 307-312
  • 2 Yonemitsu S, Nishimura H, Shintani M, Inoue R, Yamamoto Y, Masuzaki H, Ogawa Y, Hosoda K, Inoue G, Hayashi T, Nakao K. Diabetes. 2001;  50 1093-1101
  • 3 Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T. J Biol Chem. 2006;  281 8748-8755
  • 4 Pedrini MT, Kranebitter M, Niederwanger A, Kaser S, Engl J, Debbage P, Huber LA, Patsch JR. Diabetologia. 2005;  48 756-766
  • 5 Niehaus WG, Samuelsson B. Eur J Biochem. 1968;  6 126-130
  • 6 Wills ED. Biochem J. 1969;  113 315-324
  • 7 Yanfeng C, Ying L, Yanwen W, Ying W, Changhao S. Metabolism. 2009;  58 1694-1702
  • 8 Yki-Jarvinen H. N Engl J Med. 2004;  351 1106-1118
  • 9 LeBrasseur NK, Kelly M, Tsao TS, Farmer SR, Saha AK, Ruderman NB, Tomas E. Am J Physiol Endocrinol Metab. 2006;  291 E175-E181
  • 10 Thomson DM, Winder WW. Acta Physiol (Oxf). 2009;  196 147-154

1 These authors contributed qually to this work.

Correspondence

M. T. PedriniMD 

Department of Internal

Medicine I

Medical University of Innsbruck

Anichstrasse 35

6020 Innsbruck

Austria

Telefon: +43/512/504 23326

Fax: +43/512/504 28539

eMail: michael.pedrini@i-med.ac.at